ArticleTranslational oncology2021

MicroRNA-506-3p increases the response to PARP inhibitors and cisplatin by targeting EZH2/β-catenin in serous ovarian cancers.

Yue Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.